HITE Hedge Asset Management’s AbbVie ABBV Stock Holding History

HITE Hedge Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,560	Closed	-$414K	–	96
2022 Q4	$414K	Hold	2,560	–	–	0.03%	72
2022 Q3	$344K	Hold	2,560	–	–	0.03%	82
2022 Q2	$392K	Hold	2,560	–	–	0.04%	81
2022 Q1	$415K	Hold	2,560	–	–	0.04%	124
2021 Q4	$347K	Hold	2,560	–	–	0.04%	139
2021 Q3	$276K	Hold	2,560	–	–	0.03%	141
2021 Q2	$288K	Hold	2,560	–	–	0.04%	131
2021 Q1	$277K	Hold	2,560	–	–	0.04%	151
2020 Q4	$274K	Hold	2,560	–	–	0.06%	116
2020 Q3	$224K	Sell	2,560 -140	-5%	-$13.2K	0.07%	97
2020 Q2	$265K	Buy	+2,700	New	+$238K	0.1%	85
2020 Q1	–	Sell	-2,560	Closed	-$227K	–	70
2019 Q4	$227K	Buy	+2,560	New	+$213K	0.05%	88
2019 Q2	–	Sell	-2,560	Closed	-$206K	–	72
2019 Q1	$206K	Hold	2,560	–	–	0.03%	69
2018 Q4	$236K	Hold	2,560	–	–	0.04%	61
2018 Q3	$242K	Hold	2,560	–	–	0.04%	58
2018 Q2	$237K	Hold	2,560	–	–	0.04%	54
2018 Q1	$242K	Hold	2,560	–	–	0.05%	54
2017 Q4	$248K	Hold	2,560	–	–	0.04%	62
2017 Q3	$227K	Buy	+2,560	New	+$195K	0.06%	54

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HITE Hedge Asset Management's ABBV Position: Q1 2023 in Review

HITE Hedge Asset Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 2,560 shares — an estimated $414K sold.

HITE Hedge Asset Management first reported a position in ABBV in Q3 2017 and held it in 19 quarters. The position peaked at $415K in Q1 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

HITE Hedge Asset Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
HITE Hedge Asset Management sold 2,560 AbbVie shares in Q1 2023, an estimated $414K.
HITE Hedge Asset Management first reported a position in AbbVie in Q3 2017 and held it in 19 quarters.
HITE Hedge Asset Management's AbbVie position peaked at $415K in Q1 2022.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on HITE Hedge Asset Management's 13F filing for Q1 2023, filed 15 May 2023.